BackPrestige Consumer Healthcare Overview

Prestige Consumer Healthcare Total Assets

Track Prestige Consumer Healthcare's total assets ($4.6B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$4.57B
33.13% YoYΔ $1.14B vs prior year quarter

Peer trimmed avg / median

Loading

Prestige Consumer Healthcare Total Assets History

Loading

Prestige Consumer Healthcare vs. peers: Total Assets Comparison

Loading

Prestige Consumer Healthcare Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Prestige Consumer Healthcare (PBH) FAQ

Prestige Consumer Healthcare's total assets stands at $4.6B as of June 2026. That compares with $3.4B in the prior-year period — up 33.1% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Prestige Consumer Healthcare reported $4.6B in total assets versus $3.4B a year earlier — a 33.1% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $3.4B in the prior-year period — up 33.1% year over year. Sustained growth in total assets can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Prestige Consumer Healthcare's total assets evolved across reporting periods, while the comparison chart places PBH next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, total assets is commonly used to spot outliers. Prestige Consumer Healthcare's reading of $4.6B is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.